Alternative names (3)
half-life • hasHalfLife • 半衰期Random triples
| Subject | Object |
|---|---|
| gptkb:DB01068 | 4-8.7 hours |
| gptkb:REGEN-COV_(casirivimab_and_imdevimab) | ~25-30 days |
| gptkb:interferon_gamma | 5-10 minutes (in plasma) |
| gptkb:radium_A | 3.10 minutes |
| gptkb:Allegra | 14 hours |
| gptkb:Re-Os_dating | 41.6 billion years |
| gptkb:Durvalumab | ~17 days |
| gptkb:Melatonin | 20–50 minutes |
| gptkb:Lynparza | 11.9 hours |
| gptkb:Effexor_XR | about 5 hours (venlafaxine), 11 hours (O-desmethylvenlafaxine) |
| gptkb:Seresta | 5-15 hours |
| gptkb:Lamictal_XR | 25-33 hours |
| gptkb:Fosamax | 10 years (in bone) |
| gptkb:dupilumab | ~21 days |
| gptkb:Nembutal | 15-50 hours |
| gptkb:teriparatide | about 1 hour |
| gptkb:satralizumab | 30 days |
| gptkb:TransCon_hGH | long-acting |
| gptkb:helium-3_isotope | stable (no half-life) |
| gptkb:Db-270 | 1.3 minutes |